News and Trends 8 Jun 2020 UK Startup Launches with €10M to Detect Epigenetic Signs of Cancer in Blood …cerebrospinal fluid samples to diagnose neurodegenerative disorders such as Alzheimer’s,” adds Waterhouse. Base Genomics isn’t the only firm monitoring epigenetic signs of disease. One major player in liquid biopsy, the… June 8, 2020 - 3 minutesmins - By David Kirk Share WhatsApp Twitter Linkedin Email
In Depth 5 Nov 2025 Novo Nordisk’s pipeline plan: How the pharma giant is refocusing amid major restructuring …in neurology, as two phase 3 trials investigating semaglutide in Alzheimer’s disease are due readouts by the end of this year. Previously described by a senior Novo Nordisk executive as… November 5, 2025 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 10 Apr 2024 Silencing genes to cure diseases: an in-depth look at siRNA …neurodegenerative disorders with ALN-APP for Alzheimer’s disease. The biotech giant Amgen is also developing a siRNA candidate in collaboration with Arrowhead Pharmaceuticals. Olpasiran, aimed at treating atherosclerosis by targeting apolipoprotein(a),… April 10, 2024 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 14 Dec 2022 Replay targets genetic brain disorders with new gene therapy company, Kaleibe …of adeno-associated virus (AAV) vectors (5kb). Affecting more than 6 million people worldwide, PD is the most prevalent movement disorder and second most common neurodegenerative disorder globally, after Alzheimer’s disease…. December 14, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 20 Dec 2021 The Billion-Euro European Biotech Companies in 2022 …biotech company is also developing treatments against the rare disorders amyloid light-chain amyloidosis, wild-type transthyretin amyloidosis, amyotrophic lateral sclerosis, as well as Alzheimer’s disease. Its big pharma partners include Novo… December 20, 2021 - 12 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
Startup Scout 30 Aug 2019 This Biotech Develops Epigenetic Drugs to Fight Brain Cancer …cells. There are other drugs in development that target the same protein, including drugs from the Spanish biotech Oryzon Genomics that are intended to treat Alzheimer’s disease and cancer. These… August 30, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 6 May 2025 The future of diabetes treatment: Is a cure possible? …refers to cases caused by pancreatic damage, while type 3 has been used, though controversially, to describe Alzheimer’s disease linked to insulin resistance in the brain. Type 4 and type… May 6, 2025 - 11 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Expert Advice 11 Mar 2020 Why Women’s Health Can Be a Good Investment …the Hormone Replacement Therapy (HRT) market almost overnight. After the publication that associated HRT with increased risk of breast cancer, cardiovascular disease and Alzheimer’s, despite having benefits, HRT became damaged… March 11, 2020 - 13 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
In Depth 22 Mar 2021 Can Immunotherapy Offer Hope for Parkinson’s Sufferers? …to be the case with Alzheimer’s disease. “The alpha-synuclein theory of Parkinson’s is still just a hypothesis,” Staffler says. “But we are now on the cusp of either falsifying or… March 22, 2021 - 5 minutesmins - By David Cox Share WhatsApp Twitter Linkedin Email
News and Trends 8 Jul 2021 The Top European Biotech Funding Rounds in June …demand caused by the FDA’s controversial approval of Biogen’s Alzheimer’s drug Aduhelm last month. While there has been a major backlash over the decision’s justification, many biotech companies in the… July 8, 2021 - 5 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Interview 21 Mar 2018 Do Phages Hold the Key to Modulating the Microbiome? …a huge role in our health, as well as in a variety of diseases from diabetes to cancer and Alzheimer’s. As evidence linking the microbiome to our health continues to… March 21, 2018 - 3 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 7 May 2019 Belgian Biotech Raises €30M Series A to Unlock Undruggable Targets …coupled receptors (GPCRs). There are over 800 types of these proteins, and they are involved in multiple diseases, including cancer, schizophrenia, and Alzheimer’s — it is estimated that up to… May 7, 2019 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email